We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ENTBF market cap is 452.69k. The company's latest EPS is CAD -0.0339 and P/E is -1.47.
| Year End 30 November 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 22k | 214k | 250k |
| Operating Income | -101k | -905k | -7.44M | -2.82M | 131k |
| Net Income | -146k | -4.38M | -8.89M | -8.52M | -300k |
| Year End 30 November 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.72M | 4.47M | 9.98M | 769k | 401k |
| Total Liabilities | 28k | 728k | 928k | 154k | 85k |
| Total Equity | 1.69M | 3.75M | 9.05M | 615k | 316k |
| Year End 30 November 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -102k | -2.84M | -5.62M | -1.95M | -359k |
| Investing | -85k | 1.08M | -99k | 585k | 24k |
| Financing | 95k | 4.43M | 4.98M | N/A | N/A |
| Market Cap | 452.69k |
| Price to Earnings Ratio | -1.47 |
| Price to Sales Ratio | 1.77 |
| Price to Cash Ratio | 1.29 |
| Price to Book Ratio | 1.4 |
| Dividend Yield | - |
| Shares Outstanding | 8.86M |
| Average Volume (1 week) | 343 |
| Average Volume (1 Month) | 1.03k |
| 52 Week Change | -77.97% |
| 52 Week High | 0.29 |
| 52 Week Low | 0.0225 |
| Spread (Intraday) | 0.19 (97%) |
| Company Name | Entheon Biomedical Corporation (QB) |
| Address |
10th floor, 595 howe street vancouver, british columbia V6C 2T5 |
| Website | https://www.entheonbiomedical.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
